Formation of PGD2 after allergen inhalation in atopic asthmatics.
Sladek
K
K
Dept. of Medicine, Vanderbilt University, Nashville, TN 37232.
Sheller
J R
JR
FitzGerald
G A
GA
Morrow
J D
JD
Roberts
L J
LJ
D000485:Allergens / Q000494:pharmacology*; D001249:Asthma / Q000209:etiology / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors; D004311:Double-Blind Method; D005541:Forced Expiratory Volume / Q000187:drug effects; D006969:Hypersensitivity, Immediate / Q000150:complications; D007213:Indomethacin / Q000494:pharmacology; D017999:Leukotriene E4; D008407:Mast Cells / Q000378:metabolism; D008761:Methylhistamines / Q000652:urine; D015230:Prostaglandin D2 / Q000096:biosynthesis*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011457:Prostaglandins D / Q000652:urine*; D011897:Random Allocation; D013189:SRS-A / Q000031:analogs & derivatives / Q000652:urine
D000485:Allergens; D016861:Cyclooxygenase Inhibitors; D008761:Methylhistamines; D011457:Prostaglandins D; D013189:SRS-A; C035860:9-hydroxy-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid; D017999:Leukotriene E4; D011451:Prostaglandin-Endoperoxide Synthases; D015230:Prostaglandin D2; D007213:Indomethacin